NTRK1 and neoplasm: Tumours with somatic alterations in members of the receptor tyrosine kinase (RTK) pathway were most frequently found in Myeloid Predominant (Cochran-Mantel–Haenszel (CMH) test, p = 6.1 × 10−5, Fig. 4F).